← SynDRA
TRIOXSALEN
SynDRA canonical compound SYN0007671 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | DNA synthesis inhibitor |
|---|
| Indication | eczema | vitiligo |
|---|
| Disease area | dermatology |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- KCNH2
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- LCK
- KDM4E
- HTR6
- NPY2R
- HTR3A
- HTR2B
- HTR2A
- HTR1A
- HRH2
- HRH1
- HMGCR
- HDAC6
- GLP1R
- GHSR
- FYN
- NPY1R
- ACHE
- ADORA1
- SAMHD1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Dermatologic Agents
- Photosensitizing Agents
- Radiation-Sensitizing Agents
- Psoralen
ATC classes
- D05A · ANTIPSORIATICS FOR TOPICAL USE
- D05B · ANTIPSORIATICS FOR SYSTEMIC USE
Cross-references
Synonyms
- TRISORALEN
- trimethylpsoralen
- trioxysalen
- trisoralen
- Trioxysalen
- Trioxysalene
- Trioxisaleno
- 4,5',8-trimethylpsoralen
- Tmp (psoralen)
- NSC-71047
- Trisoralen
- Trimethylpsoralen
- 4,5',8-Trimethylpsoralen
- Elder 8011
- Trioxysalenum
- 2',4,8-Trimethylpsoralen
- 4,5',8-Trimethylpsoralene
- NSC 71047
- UNII-Y6UY8OV51T
- Trioxysalene [INN-French]
- Trioxysalenum [INN-Latin]
- NSC71047
- Trioxisaleno [INN-Spanish]
- TRIOXSALIN
- EINECS 223-459-0
- 4,8,5'-Trimethylpsoralen
- BRN 0221723
- Y6UY8OV51T
- DTXCID403716
- CHEBI:28329
- Trioxisalenum
- trioxisalene
- RefChem:58176
- D05AD01
- D05BA01
- MFCD00005010
- Trioxysalen [INN]
- Trisoralen;Trioxysalen;TMP
Look up TRIOXSALEN in the interactive SynDRA portal →